Literature DB >> 26680668

Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study.

H Pikhart1, J A Hubáček, A Peasey, R Kubínová, M Bobák.   

Abstract

Dyslipidemia is the risk factor of cardiovascular disease, but the relationship between the plasma triglyceride (TG) levels and total/cardiovascular mortality has not yet been analyzed in Slavs. The aim of our study was to analyze the association between the fasting TG levels and all-cause/cardiovascular mortality. We have examined 3,143 males and 3,650 females, aged 58.3+/-7.1 years. 729 deaths (274 cardiovascular deaths) have been registered during up to 11.8 years of follow-up. Age-sex adjusted all-cause mortality was higher in individuals with TG values 3.01-4.00 mmol/l (HR 1.37, 95 % CI 1.02-1.83, P=0.035) and over 4.00 mmol/l (HR 1.66, 95 % CI 1.21-2.27, P=0.002) when compared with a reference group (TG 1.41-1.80 mmol/l). Elevated risk remains significant when adjusted for education, marital status and unemployment. When further adjusted for smoking, BMI and dyslipidemia interventions, HR for those in above 4.00 mmol/l group decreased (1.42, P=0.04). The results have been similar when cardiovascular mortality has been examined, however, results reached statistical significance only for the TG over 4.0 mmol/l (P=0.028). Our results confirmed that enhanced plasma levels of plasma triglycerides are dose dependently associated with increased risk of all-cause mortality, however, it seems that individuals with TG values 1.8-3.0 mmol/l are not in higher risk of death.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26680668     DOI: 10.33549/physiolres.933179

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  6 in total

1.  The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control Study.

Authors:  Jaroslav A Hubacek; Dana Dlouha; Vera Adamkova; Lucie Schwarzova; Vera Lanska; Richard Ceska; Martin Satny; Michal Vrablik
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 2.  Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.

Authors:  Jaroslav A Hubacek
Journal:  Gene       Date:  2016-08-02       Impact factor: 3.688

3.  Association of c.56C > G (rs3135506) Apolipoprotein A5 Gene Polymorphism with Coronary Artery Disease in Moroccan Subjects: A Case-Control Study and an Updated Meta-Analysis.

Authors:  Imane Morjane; Hicham Charoute; Sanaa Ouatou; Lamiae Elkhattabi; Houda Benrahma; Rachid Saile; Hassan Rouba; Abdelhamid Barakat
Journal:  Cardiol Res Pract       Date:  2020-08-04       Impact factor: 1.866

4.  Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: A systematic review.

Authors:  Eduarda Barreira; André Novo; Josiana A Vaz; Ana M G Pereira
Journal:  Aten Primaria       Date:  2017-10-21       Impact factor: 1.137

5.  Longitudinal trajectories of blood lipid levels in an ageing population sample of Russian Western-Siberian urban population.

Authors:  Jaroslav A Hubacek; Yuri Nikitin; Yulia Ragino; Ekaterina Stakhneva; Hynek Pikhart; Anne Peasey; Michael V Holmes; Denes Stefler; Andrey Ryabikov; Eugeny Verevkin; Martin Bobak; Sofia Malyutina
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

6.  Global DNA methylation in rats´ liver is not affected by hypercholesterolemic diet.

Authors:  L Jurcikova-Novotna; L Mrazova; K Mičová; D Friedecký; J A Hubacek; R Poledne
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.